NCT04751877
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- CHU Poitiers Poitiers, France
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,001 public trials
2,038 recruiting studies
Immunoproliferative Disorders trial results
Active, not recruiting
Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
NCT03710603
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Alfred Hospital Melbourne, Australia
- University Hospital Leuven Leuven, Belgium
- University Hospital Ostrava Ostrava, Czechia
- Odense University Hospital Odense, Denmark
Active, not recruiting
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
NCT04850846
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Dana-Farber at Brighton Brighton, Massachusetts, United States
- Dana-Farber at Merrimack Valley Methuen, Massachusetts, United States
Active, not recruiting
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
NCT00586391
- Conditions
- Acute Lymphocytic Leukemia, B Cell Lymphoma, Chronic Disease, +20 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Active, not recruiting
EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma
NCT01192464
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Active, not recruiting
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
NCT03513562
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
NCT06485219
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Disease Attributes, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Ruijin Hospital, Shanghai Jiaotong University School Of Medicine Shanghai, Shanghai Municipality, China
- West China Hospital Sichuan University Chengdu, Sichuan, China
Active, not recruiting
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
NCT03933735
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of California San Francisco (UCSF) - Parnassus Heights /ID# 238680 San Francisco, California, United States
- Tulane University School of Medicine /ID# 242322 New Orleans, Louisiana, United States
- Mayo Clinic - Rochester /ID# 238683 Rochester, Minnesota, United States
- Washington University-School of Medicine /ID# 238681 St Louis, Missouri, United States
Active, not recruiting
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT03749018
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
NCT06097364
- Conditions
- Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States
- Investigative Clinical Research of Indiana Noblesville, Indiana, United States
- Cancer Center of Kansas Wichita, Kansas, United States
- University of Kentucky Lexington, Kentucky, United States